Similarly, CCR1 and ITGB7 contribute to critical tumor-stroma interactions that drive MM cell migration, adhesion, and drug resistance, emphasizing their therapeutic relevance [124, 125]. This evidence concerns the gene CCR1 and Miyoshi myopathy.